Biotechnology Stocks I Performance Guide: Regeneron Pharmaceuticals, Inc. (REGN)
REGN has no dividends.
Table and Chart of REGN Performance
See what a $1,000 investment in REGN is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| REGN Returns | |
|---|---|
| Start Date | May-30-2014 |
| Start Price | $306.96 |
| End Date | May-10-2024 |
| End Price | $973.80 |
| # Prices | 121 |
| Min Date | Sep-30-2019 |
| Min Price | $277.40 |
| Max Date | May-10-2024 |
| Max Price | $973.80 |
| Total Return | 217.24% |
| Annualized Return | 12.13% |
| Current Value of $1,000 Purchase | $3,172 |
| Number Returns | 7,260 |
| Average Return | 40.76% |
| Number Profitable Returns | 5,485 |
| Percent Profitable Returns | 75.55% |
| Number Unprofitable Returns | 1,775 |
| Percent Unprofitable Returns | 24.45% |
| Profitable to Unprofitable Returns Ratio | 3.09 |
| REGN Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $107,299,127,000 |
| Beta | 0.168 | Price to Sales | 7.57 |
| Earnings per Share | $33.8900 |
| PE Ratio | 28.73 |
| PE to Growth Ratio | 1.459 |
| Price to Book | 3.823 |
| PRICE DATA | |
| 52 Week High | $998.33 |
| 52 Week Low | $684.8 |
| Analyst Target Price | $1053.6 |
| 50-Day Moving Average | $942.3 |
| 200-Day Moving Average | $874.76 |
| FINANCIAL DATA | |
| Revenue per Share | $122.57 |
| Revenue | $13,100,100,000 |
| Profit Margin | 29.4% |
| Return on Equity | 15.3% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
REGN Compare Returns with S&P 500
REGN Trendline Chart
REGN Moving Average Chart
REGN Stock Return Map - See Patterns of Gains and Losses
REGN Stock Returns/Purchase Dates